| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 2,024 | 1,705 | 1,752 | 3,622 | | Cost of Revenue | 1,183 | 1,316 | 1,387 | 3,012 | | | Gross Profit | 574 | 389 | 366 | 610 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,158 | 1,399 | 1,980 | 4,519 | | Non Recurring |
-
| 591 |
-
| (684) | | Others | 50 | 132 | 131 | 127 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (634) | (1,141) | (1,745) | (3,352) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,561 | 78 | 869 | 361 | | Earnings Before Interest And Taxes | 677 | (1,405) | (876) | (2,916) | | Interest Expense | 15 | 23 | 40 | 97 | | Income Before Tax | 662 | (1,428) | (916) | (3,013) | | Income Tax Expense | (65) | (12) |
-
| (40) | | Minority Interest | (23) | 11 |
-
| 75 | | | | Net Income From Continuing Ops | 453 | (1,154) | (916) | (2,972) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 703 | (1,404) | (916) | (2,972) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $703 | ($1,404) | ($916) | ($2,972) |
|
0.28% Nasdaq 0.00%
Income Statement
